Overview

A Study of Surgery and Radiotherapy in People With Breast Cancer

Status:
RECRUITING
Trial end date:
2029-09-17
Target enrollment:
Participant gender:
Summary
The researchers are doing this study to see if the combination of surgery, locoregional radiation therapy, SBRT (stereotactic body radiation therapy), and the usual approach is more effective in treating oligometastatic HER2-positive breast cancer than the usual approach alone. The researchers will also study the side effects of the study treatment.
Phase:
PHASE2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborator:
Gateway for Cancer Research
Treatments:
Mastectomy
Mastectomy, Segmental
Paclitaxel
pertuzumab
Radiotherapy
Trastuzumab